Showing results (1-10 of 838) with videos related to

Sort By:
Pageof 84
BJU International|December 12, 2007
Activity of different phospholipids in attenuating hyperactivity in bladder irritationPradeep Tyagi, Michael Chancellor, Naoki Yoshimura, et al.
Molecular Pharmaceutics|August 8, 2006
Recent advances in intravesical drug/gene deliveryPradeep Tyagi, Pao-Chu Wu, Michael Chancellor, et al.
Molecular Pharmaceutics|August 8, 2006
Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugatesPradeep Tyagi, Rajkumar Banerjee, Soumitra Basu, et al.
Pharmaceutical Research|June 8, 2004
Sustained intravesical drug delivery using thermosensitive hydrogelPradeep Tyagi, Zhenhua Li, Michael Chancellor, et al.
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Functional role of cannabinoid receptors in urinary bladderPradeep Tyagi, Vikas Tyagi, Naoki Yoshimura, et al.
Life Sciences|October 30, 2016
Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factorMahendra Kashyap, Subrata Pore, Michael Chancellor, et al.
Bladder (San Francisco, Calif.)|December 29, 2015
Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxationMahendra Kashyap, Naoki Yoshimura, Phillip P Smith, et al.
The Journal of Urology|November 23, 2016
Past, Present and Future of Chemodenervation with Botulinum Toxin in the Treatment of Overactive BladderPradeep Tyagi, Mahendra Kashyap, Naoki Yoshimura, et al.
ISRN Pharmacology|February 15, 2014
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndromePradeep Tyagi, Mahendra P Kashyap, Naoki Kawamorita, et al.
The Journal of Urology|March 5, 2013
Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladderMahendra Kashyap, Naoki Kawamorita, Vikas Tyagi, et al.
Pageof 84